1 completed, 1 recruiting. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Recruiting 1 |
Follow Childhood: new trials by email Literature Review of Childhood trials Research Report on Childhood
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults GPC2-CAR T cells, Fludarabine, Cyclophosphamide - Medulloblastoma, Central Nervous System Embryonal Tumor | Phase 1 | Recruiting | Stanford University | 18 | 2025-08-28 | 2026-10-09 |
| Bioavailability of Stiripentol After Single Oral Dose of Capsule vs Suspension in Healthy Subjects (STILIQ) Stiripentol capsule (Diacomit®), Stiripentol oral suspension (Diacomit®) - Dravet Syndrome, Epilepsy | Phase 1 | Completed | Biocodex | 24 | 2025-06-01 | 2025-09-16 |
Brain Neoplasms (1) · Epilepsies, Myoclonic (1) · Epilepsy (1) · Medulloblastoma (1) · Neuroectodermal Tumors, Primitive (1) · Pinealoma (1) · Rhabdoid Tumor (1)
Brain Diseases (2) · Central Nervous System Diseases (2) · Nervous System Diseases (2) · Central Nervous System Neoplasms (1) · Epilepsy, Generalized (1) · Epileptic Syndromes (1) · Glioma (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Complex and Mixed (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Glandular and Epithelial (1) · Neoplasms, Nerve Tissue (1) · Neoplasms, Neuroepithelial (1)
Cyclophosphamide (1) · Suspensions (1) · fludarabine (1) · stiripentol (1)
Biocodex (1) · Stanford University (1)
France (1) · United States (1)